Retroviral self-inactivation in the mouse vagina induced by short DNA

Antiviral Research

Volumn 82, Issue 1, 2009, Pages 22-28

  Wittmer Elzaouk, Lina ^a   Jung Shiu, Jiunshan ^a   Heinrich, Jochen ^a   Moelling, Karin ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b INSTITUTE FOR ADVANCED STUDY   (United States)

Author keywords

Hairpin loop DNA; HIV; Lentiviral vector; Microbicide; RNase H; Virus suicide

Indexed keywords

COMPLEMENTARY DNA; LENTIVIRUS VECTOR; OLIGODEOXYNUCLEOTIDE; RIBONUCLEASE H; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA TRANSCRIPTION; EMBRYO; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MOUSE; NONHUMAN; POLYPURINE TRACT; PRIORITY JOURNAL; VAGINA; VIRUS GENE; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS PARTICLE; VIRUS RECOMBINANT;

ANIMALS; ANTIVIRAL AGENTS; BASE SEQUENCE; CELL LINE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES; VAGINA; VIRUS INACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; MURINAE;

EID: 62049085212     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.01.002     Document Type: Article

References (19)

1. Abel K., Compton L., Rourke T., Montefiori D., Lu D., Rothaeusler K., Fritts L., Bost K., and Miller C.J. Simian-human immunodeficiency virus SHIV89. 6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses. J. Virol. 77 (2003) 3099-3118
2. Crinelli R., Bianchi M., Gentilini L., Palma L., and Magnani M. Locked nucleic acids (LNA): versatile tools for designing oligonucleotide decoys with high stability and affinity. Curr. Drug Targets 5 (2004) 745-752
3. Fichorova R.N., Rheinwald J.G., and Anderson D.J. Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol. Reprod. 57 (1997) 847-855
4. Heinrich J., Mathur S., Matskevich A.A., and Moelling K. Oligonucleotide-mediated retroviral RNase H activation leads to reduced HI-1 titer in patient-derived plasma. AIDS 23 (2009) 213-221
5. Jendis J., Strack B., and Moelling K. Inhibition of replication of drug-resistant HIV type 1 isolates by polypurine tract-specific oligodeoxynucleotide TFO A. AIDS Res. Hum. Retroviruses 14 (1998) 999-1005
6. Jendis J., Strack B., Volkmann S., Böni J., and Mölling K. Inhibition of replication of fresh HIV type 1 patient isolates by a polypurine tract-specific self-complementary oligodeoxynucleotide. AIDS Res. Hum. Retroviruses 12 (1996) 1161-1168
7. Khanna K.V., Whaley K.J., Zeitlin L., Moench T.R., Mehrazar K., Cone R.A., Liao Z., Hildreth J.E., Hoen T.E., Shultz L., and Markham R.B. Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J. Clin. Invest. 109 (2002) 205-211
8. Lois C., Hong E.J., Pease S., Brown E.J., and Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295 (2002) 868-872
9. Macartney K.K., Baumgart D.C., Carding S.R., Brubaker J.O., and Offit P.A. Primary murine small intestinal epithelial cells, maintained in long-term culture, are susceptible to rotavirus infection. J. Virol. 74 (2000) 5597-5603
10. Matskevich A.A., Ziogas A., Heinrich J., Quast S.A., and Moelling K. Short partially double-stranded oligodeoxynucleotide induces reverse transcriptase/RNase H-mediated cleavage of HIV RNA and contributes to abrogation of infectivity of virions. AIDS Res. Hum. Retroviruses 22 (2006) 1220-1230
11. Matzen K., Elzaouk L., Matskevich A.A., Nitzsche A., Heinrich J., and Moelling K. RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides. Nat. Biotechnol. 25 (2007) 669-674
12. McCormack S., Hayes R., Lacey C.J., and Johnson A.M. Microbicides in HIV prevention. BMJ 322 (2001) 410-413
13. Miller C.J., and Abel K. Immune mechanisms associated with protection from vaginal SIV challenge in rhesus monkeys infected with virulence-attenuated SHIV 89.6. J. Med. Primatol. 34 (2005) 271-281
14. Moelling K., Abels S., Jendis J., Matskevich A., and Heinrich J. Silencing of HIV by hairpin-loop-structured DNA oligonucleotide. FEBS Lett. 580 (2006) 3545-3550
15. Moelling K., Bolognesi D.P., Bauer H., Busen W., Plassmann H.W., and Hausen P. Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids. Nat. New Biol. 234 (1971) 240-243
16. Roberts J.N., Buck C.B., Thompson C.D., Kines R., Bernardo M., Choyke P.L., Lowy D.R., and Schiller J.T. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 13 (2007) 857-861
17. Stone A. Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Nat. Rev. Drug Discov. 1 (2002) 977-985
18. Westerhout E.M., ter Brake O., and Berkhout B. The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference. Retrovirology 3 (2006) 57
19. Wöhrl B.M., and Moelling K. Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids. Biochemistry 29 (1990) 10141-10147